Research progress on tumor-infiltrating lymphocyte therapy for cervical cancer [0.03%]
宫颈癌肿瘤浸润淋巴细胞治疗的研究进展
Wei Zhang,Yong-Min Liu,Dong Li et al.
Wei Zhang et al.
Cervical cancer is a common malignant tumor in women, and human papillomavirus (HPV) infection is a major cause of cervical cancer. Tumor-infiltrating lymphocytes (TILs) are a heterogeneous group of lymphocytes primarily composed of T lymph...
The novel role of Yin Yang 1 in acute rejection of liver allografts through activation of dendritic cells [0.03%]
Yin Yang 1在肝移植急性排斥反应中通过活化树突状细胞所起的新作用
Yi Chen,Jie Wang,Liping Hong et al.
Yi Chen et al.
Introduction: Acute rejection is a critical complication after liver transplantation, contributing significantly to transplant dysfunction and recipient mortality. Yin Yang 1 (YY1), a zinc-finger transcription factor, has...
Anna Henning,Johanna Seer,Johannes Zeller et al.
Anna Henning et al.
Introduction: The pentameric C-reactive protein (pCRP), an acute-phase protein, binds to lysophosphatidylcholine (LPC) displayed on the surface of dying cells and microorganisms to activate the complement system and to op...
Multi-omics analyses construct an inflammatory response based prognostic gene signature for cervical cancer and suggest tumor infiltrating monocytes subgroups as key players [0.03%]
多组学分析构建了基于炎症反应的宫颈癌预后基因标志物并提示肿瘤浸润单核细胞亚群为关键角色
Yidong Zhang,Jiawei Zhu,Ke Hu et al.
Yidong Zhang et al.
Background: Inflammatory response in the tumor micro-environment contributes to the progression and treatment response of various types of cancers. However, for cervical cancer, a type of cancer initiated by the infection...
First successful treatment of epidermolytic Ichthyosis with Vunakizumab: A Case Report [0.03%]
乌纳利珠单抗成功治疗板层状鱼鳞病1例报告
Wenjie Cheng,Chaolan Pan,Zhe Sun et al.
Wenjie Cheng et al.
Ichthyoses, a group of skin cornification disorders caused by protein and lipid abnormalities that disrupt epidermal functions, are mainly characterized by generalized scaling. This study is the first to report the use of Vunakizumab, China...
Transcriptomic profiling of cytomegalovirus infection in cardiac transplantation: proof-of-concept for a new strategy in tissue markers application [0.03%]
巨细胞病毒感染心脏移植的转录组谱分析：组织标记物应用新策略的概念验证
Ilaria Barison,Diego Perazzolo,Chiara Castellani et al.
Ilaria Barison et al.
Background: Cytomegalovirus (CMV) infection is a relevant threat to heart-transplanted patients during the first year after surgery, leading to increased morbidity and, in some cases, mortality. This proof-of-concept stud...
Case Report: FAP+ fibroblasts and SPP1+ macrophages in SMARCA2-deficient while SMARCA4-preserved poorly differentiated lung adenocarcinoma: two case reports and multi-omics analysis [0.03%]
病例报告：SMARCA2 缺陷型而 SMARCA4 保全型肺腺癌的 FAP+ 成纤维细胞和 SPP1+ 巨噬细胞：两例报道及多组学分析
Zhaoxuan Wang,Junying Wang,Shengmin Wang et al.
Zhaoxuan Wang et al.
Two ATPase subunits, SMARCA4 (which encodes BRG1) and SMARCA2 (which encodes BRM), facilitate this process by hydrolyzing ATP to energize the activity of the mammalian switch/sucrose-non-fermenting (mSWI/SNF) complexes. Clinically, SMARCA4-...
Development of a multi-neoepitope vaccine targeting non-small cell lung cancer through reverse vaccinology and bioinformatics approaches [0.03%]
基于反向疫苗学和生物信息学方法开发用于非小细胞肺癌的多新抗原疫苗
Elahe Asadollahi,Alireza Zomorodipour,Zahra-Soheila Soheili et al.
Elahe Asadollahi et al.
Introduction: Lung cancer, predominantly non-small cell lung cancer (NSCLC), is the leading cause of cancer-related mortality worldwide. Among immunotherapeutic strategies, the personalized multi-neoepitope vaccine (MNEV)...
Engineered sequestrins inhibit aggregation of pathogenic alpha-synuclein mutants [0.03%]
工程化捕获蛋白可抑制致病性α-突触核蛋白突变体的聚集
Linnea Charlotta Hjelm,Wojciech Paslawski,Christofer Lendel et al.
Linnea Charlotta Hjelm et al.
Misfolding and aggregation of the neuronal protein alpha-synuclein (aSyn) has been identified as a hallmark of Parkinson's disease (PD) pathology and other synucleinopathies. Preventing formation of intracellular aSyn accumulations constitu...
Corrigendum: Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis [0.03%]
程序性死亡受体1及其配体1抑制剂一线治疗食管鳞癌疗效和安全性的系统评价和meta分析（更正）
Wei Ren,Hanyu Zhang,Yixin Li et al.
Wei Ren et al.
[This corrects the article DOI: 10.3389/fimmu.2025.1563300.]. Keywords: PD-1/PD-L1 inhibitor; combined posit...
Published Erratum
Frontiers in immunology. 2025 May 16:16:1611591. DOI:10.3389/fimmu.2025.1611591 2025